Skip to main content

Want a detailed portfolio tracker?

Performance analysis of Chemomab Therapeutics (CMMB)

Annual Return

Over the past 3 years, CMMB has had an average annual return of -37.03%, underperforming the benchmark SPY, which returned +22.45% annual.

Over the past 5 years, CMMB has had an average annual return of -52.67%, underperforming the benchmark SPY, which returned +13.88% annual.

Since Feb 12, 2019, CMMB has had an average annual return of -55.94%, underperforming the benchmark SPY, which returned +16.58% annual.

20262025202420232022202120202019
+4.17%-77.14%+250%-83.78%-53.63%-75.09%+23.61%-87.04%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2026-8.33%+22.73%-14.81%-8.70%+38.10%-13.79%+4.17%
2025+12.38%-17.80%-35.05%+23.81%-2.56%-11.84%-7.46%-27.42%-15.56%+15.79%-13.64%-36.84%-77.14%
2024+10%+21.21%+12.50%-8.89%+51.22%-14.52%+28.30%+72.06%-22.22%-9.89%+28.05%+0%+250%
2023-28.11%-32.33%+2.22%-6.52%+5.81%-16.48%-2.63%-13.51%-18.75%-19.23%-26.19%-3.23%-83.78%
2022-28.82%-11.62%+10.76%-34.53%-2.20%+20.22%-17.29%+7.34%-24.21%-18.06%+3.39%+51.64%-53.63%
2021+20.22%+74.51%-50.58%+3.01%-40.15%+7.52%-12.62%-11.75%-24.50%-9.36%-7.92%-25.42%-75.09%
2020-8.56%-29.79%-12.50%+13.74%+23.07%+24.53%-29.39%+1.12%+16.56%+13.07%+20.94%+10.94%+23.61%
2019-25.93%-15.05%-14.27%-14.16%-10.41%-33.70%-16.84%-6.91%+0.47%-38.94%-0.77%-87.04%

Drawdown analysis of Chemomab Therapeutics (CMMB)

The maximum drawdown for the CMMB was -99.79%, occurring on Feb 5, 2026. This drawdown has not yet recovered.

The current CMMB drawdown is -99.75%.

Since Feb 12, 2019 CMMB has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 1 time
  • 30% or more: 1 time
  • 20% or more: 1 time
  • 10% or more: 1 time
DepthStartTo BottomBottomTo RecoverEndTotal
-99.79%Feb 12, 20191754Feb 5, 2026OngoingOngoingOngoing